Prostaglandin Receptor EP2 Antagonists, Derivatives, and Uses Related Thereto

Abstract: the disclosure relates to prostaglandin receptor ep2 antagonists, derivatives, compositions, and methods related thereto. in certain embodiments, the disclosure relates to methods of treating or preventing conditions and diseases in which ep2 receptor activation has a physiological role, such as but not limited to, brain injury, inflammatory diseases, epilepsy, neuroinflamation after a seizure, pain, endometriosis, cancer, rheumatoid arthritis, skin inflammation, vascular inflammation, colitis, and neurological disorders by administering a pharmaceutical composition comprising a compound disclosed herein to a subject in need thereof.

Inventor(s): Thota Ganesh, Raymond J. Dingledine, Radhika Amaradhi, Shabber Mohammed

CPC Classification: C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds ))

Search for rejections for patent application number 20250206721